BioCanCell's IPO

BioCanCell raised a round of funding on August 01, 2006. Investors include Public.

BioCanCell is a clinical-stage biopharmaceutical company dedicated to discovering and developing new therapies to treat cancer.…

Articles about BioCanCell's IPO: